Institute of Medicine

Committee on a Review of the California Institute for Regenerative Medicine

Location:
South San Francisco Conference Center
255 South Airport Boulevard
South San Francisco, CA 94080

OPEN SESSION AGENDA

Date: January 24, 2012

9:00 a.m. WELCOME AND COMMITTEE INTRODUCTIONS

Harold T. Shapiro, Ph.D.
IOM Committee Chair

9:10 a.m. EVOLVING SCIENTIFIC PRIORITIES AT CIRM

Alan Trounson, Ph.D.
CIRM President

10:10 a.m. OVERVIEW OF CIRM SCIENTIFIC AND MEDICAL ACCOUNTABILITY
STANDARDS WORKING GROUP

Bernard Lo, M.D.
Standards Working Group Co-Chair

10:50 a.m. BREAK

11:00 a.m. CIRM INTELLECTUAL PROPERTY POLICIES

Duane J. Roth
CIRM Governing Board Vice Chair and Intellectual Property/Industry Subcommittee Member

11:40 a.m. OVERVIEW OF CIRM TRANSITION PLAN

Jonathan Thomas, J.D., D.Phil.
Chair, CIRM Governing Board

12:20 p.m. LUNCH

1:15 p.m. PERSPECTIVES ON CIRM FROM THE PATIENT ADVOCACY COMMUNITY

Jeff Sheehy
Co-Vice Chair of the Scientific and Medical Research Funding Working Group
CIRM Patient Advocate Board Member
Director of Communications
AIDS Research Institute
University of California, San Francisco

1:50 p.m. PERSPECTIVES ON CIRM FROM PRINCIPAL INVESTIGATORS

Irina Conboy, Ph.D.
Assistant Professor, Department of Bioengineering
University of California, Berkeley

John P. Murnane, Ph.D.
Professor, Department of Radiation Oncology
University of California, San Francisco

Howard Y. Chang, M.D., Ph.D.
Stanford University School of Medicine
Howard Hughes Medical Institute

Helen M. Blau, Ph.D.
Donald E. and Delia B. Baxter Professor
Director
Baxter Laboratory for Stem Cell Biology
Stanford University School of Medicine

Frederick J. Meyers, M.D., M.A.C.P. (by phone- invited)
Executive Associate Dean
University of California, Davis, School of Medicine

Alice F. Tarantal, Ph.D. (by phone)
Professor and Vice-Chair for Research
Department of Pediatrics
University of California, Davis, School of Medicine

3:15 p.m. BREAK

3:30 p.m. RECAP/DISCUSSION OF MORNING AND AFTERNOON PRESENTATIONS

4:00 p.m. PUBLIC COMMENT

Individuals register for a slot and have 5 minutes for comments on any topic related to the study charge.

Register to speak at this URL:
http://www.surveygizmo.com/s3/768937/HSP-Committee-on-a-Review-of-CIRM-Meeting-2-1-24-12

5:00 p.m. ADJOURN OPEN SESSION

This meeting is being held to gather information to help the committee conduct its study. This committee will examine the information and material obtained during this, and other public meetings, in an effort to inform its work. Although opinions may be stated and lively discussion may ensue, no conclusions are being drawn at this time; no recommendations will be made. In fact, the committee will deliberate thoroughly before writing its draft report. Moreover, once the draft report is written, it must go through a rigorous review by experts who are anonymous to the committee, and the committee then must respond to this review with appropriate revisions that adequately satisfy the Academy's Report Review committee and the chair of the NRC before it is considered an NRC report. Therefore, observers who draw conclusions about the committee's work based on today's discussions will be doing so prematurely.

Furthermore, individual committee members often engage in discussion and questioning for the specific purpose of probing an issue and sharpening an argument. The comments of any given committee member may not necessarily reflect the position he or she may actually hold on the subject under discussion, to say nothing of that person's future position as it may evolve in the course of the project Any inference about an individual's position regarding findings or recommendations in the final report are therefore also premature.